Posted by ABMN Staff on May 5th, 2024
Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by equities researchers at UBS Group from $284.00 to $307.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has...
More of this article »